21 Mar 2022 , 04:49 PM
SMS Pharmaceuticals announced the successful completion of remote regulatory assessment by USFDA for its testing facility, SMS Pharmaceuticals (Central Laboratory Analytical Services) in Telangana and received Remote Assessment Report. As a result of this remote assessment, USFDA does not plan to take or recommend regulatory or enforcement action at this time.
The Central Laboratory Analytical Services is an independent testing laboratory, and this was the first Remote Regulatory Assessment [704(a)(4) Record Review] by USFDA and completed successfully.
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
